APPLICATIONS PUBLISHED 19 MARCH 2003
Published: 1-Sep-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Preparations that contain an extract of the plant Pistia stratiotes
Cognis France 1292278*
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
Teva Pharmaceutical Industries 1292279*
Multiple stimulus reversible hydrogels
Battelle Memorial Institute 1292280*
Novel tiotropium-containing inhalation powder
Boehringer Ingelheim Pharma 1292281*
Improved injectable dispersions of propofol
RTP Pharma 1292282*
A medicinal aerosol formulation
Aeropharn Technology 1292283*
Encapsulation of polynucleotides and drugs into targeted liposomes
Boulikas, Teni 1292284*
Delivery systems for bioactive agents
Zycos 1292285*
Dry-powder pharmaceutical formulation for inhalation comprising alpha-4-integrin antagonist
Glaxo Group 1292286*
Method for enhancing cognitive function
SmithKline Beecham 1292287*
2-arachnidonylglycerol (2-AG) an inhibitor of tumour necrosis factor-alpha and neuroprotector of brain in closed head injury
Yissum Research Development Company of the Hebrew University of Jerusalem 1292288*
Compsns and methods for treating neoplastic disease using chemotherapy and radiation sensitisers
Chiron 1292289*
Pharmaceutical compsns comprising acryloyl distamycin derivatives and topoisomerase I and II inhibitors
Pharmacia Italia 1292290*
Use of C4-C10 acids for preventing gram-negative bacterial infections
Institut Pasteur 1292291*
Method for treating congestive heart failure
North Shore-Long Island Jewish Research Institute 1292292*
Stabilised phrmaceutically-effective compsn and pharmaceutical formulation comprising the same
Lek Pharmaceutical and Chemical 1292293*
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
Accera 1292294*
Supplement to enhance fertility
JSR Clover 1292295*
Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
AstraZeneca 1292296*
Pharmaceutical combination of blicalutamide and anastrazole for providing an anti-androgenic effect and aromatase inhibition
AstraZeneca 1292297*
Intracorporeal medicaments for high energy phototherapeutic treatments of disease
Photogen 1292298*
New use of citreamycins
Insituto Biomar 1292299*
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
SmithKline Beecham plc; SmithKline Beecham Corp 1292300*
Treatment and prevention of cardiac insulin resistance associated conditions
SmithKline Beecham 1292301*
Method of treating cardiovascular disease using rapamycin
Wyeth 1292302*
A stable pharmaceutical formulation comprising torsemide modification II
Teva Pharmaceutical Industries 1292303*
Zolpidem hemitartate
Teva Pharmaceutical Industries 1292304*
Method of dopamine inhibition using L-threo-methylphenidate
The McLean Hospital Corp 1292305*
A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2-(3H)furanone
Nicholas Piramal India; Council of Scientific and Industrial Research 1292306*
Method of treating pain using nalbuphine and opioid antagonists
The Regents of the University of California 1292307*
Alpha, beta-unsaturated sulphones for treating proliferative disorders
Temple University of the Commonwealth System of Higher Education 1292308*
Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical formulation containing oltipraz
Kim, Sang Geon 1292309*
Novel anti-infectives
SmithKline Beecham 1292310*
Combination therapy for the treatment of depression comprising an antidepressant and an AMPA receptor potentiator
Eli Lilly 1292311*
Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
Sigma-Tau Healthscience 1292312*
Methods for treating hepatitis delta virus infection with beta-L-2'-deoxy-nucleosides
Idenix (Cayman) 1292313*
Methods for treating respiratory disorders associated with pulmonary elastic fibre comprising the use of glycosaminoglycans
The Trustees of Columbia University in the City of New York 1292314*
Methods and compsns using sulodexide for the treatment of diabetic nephropathy
Alfa Wassermann 1292315*
Hemostatic compsns of polyacids and polyalkylene oxides and methods for their use
Fziomed 1292316*
Hypotensive and hypertensive properties of renomedullar extracts
Angion 1292317*
Extracts from spermatophyte plants with antitumour activity
Consiglio Nazionale Delle Richerche 1292319*
Extracts from spermatophyte plants with immunomodulating activity
Consiglio Nazionale Delle Richerche 1292320*
Method to increase class 1 presentation of exogenous antigens by human dendritic cells
NorthWest Biotherapeutics 1292321*
Immunosuppressor agent derived from morbillivirus
Institut National de la Sante et de la Recherche Medicale 1292322*
Inhibition of SMAD3 to prevent fibrosis and improve wound healing
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1292323*
Critical illness neuropathy
Novo Nordisk, KU Leuven Research & Development 1292324*
Matrix protein compsns for dentin regeneration
Biora 1292325*
Recombinant human CLN2 protein and methods of its product and use
University of Medicine and Dentistry of New Jersey 1292326*
Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
Medimmune 1292328*
manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
The UAB Research Foundation 1292329*
Immunostimulating properties of a fragment of TNF-beta
Vaccine Chip Technology 1292330*
Immunostimulatory RNA/DNA hybrid molecules
Biosynexus Inc 1292331*
Adjuvants and process to induce a specific type of immune response
Baylor Research Institute 1292332*
Adjuvant compsn comprising FHA protein or fragment of FHA protein in free form
Institut Pasteur de Lille; Institut National de la Sante et de la Recherche Medicale 1292333*
Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
Idec Pharmaceuticals 1292334*
Combinations and compsns which interfere with VEGF/VEGF and angiopoietin/TIE receptor function and their use (II)
Schering 1292335*
Conjugates of aminodrugs comprising an oxime bond
Instituto di Ricerche di Biologia Moleculare 1292336*
Multivalent platform molecules comprising high molecular weight polyethylene oxide
La Jolla Pharmaceutical 1292337*
Stabiliser for radiopharmaceuticals
Amersham; Nihon Medi-Physics 1292338*
Liquid collagen hemostat
Biering, Wolfgang 1292339*
Transfection system
Universitaetsklinikum Freiburg, Abteiliung Plastische and Handchirugie 1292340*
